IMAGE ANALYSIS GROUP

IMAGE ANALYSIS GROUP

Biotechnology Research

Imaging | Clinical Trials | Powered by DYNAMIKA | Fueled by Expertise

About us

IAG is a premier imaging Clinical Research Organization (iCRO) dedicated to accelerating drug development through innovative imaging solutions. Our mission: To deliver faster, more efficient clinical trials that improve patient outcomes. How we do it: * DYNAMIKA: Our cutting-edge Digital Data Management platform streamlines operations and central review, while giving managed access to data and ensuring transparency of execusion. * Operational Reach: EU, UK, USA, China, Korea, India, South America. * Global network: Access to a vast network of sites and experienced radiologists worldwide. * Therapeutic expertise: Deep understanding of imaging across multiple indications. Our track record: Over 700 successful clinical trials since 2007. Why choose IAG: * Accelerated drug development: Leverage imaging data to gain better insights into new drug safety and efficacy, reducing future development risks. *AI innovation: Partner with us to explore AI-driven solutions for your projects. *Our culture: Our team works closely with you to create a strategy that fits your needs and help executing it with emphasis on open communication, cost-efficiency and focus on results. Let's work together to bring life-changing treatments to market.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
London
Type
Privately Held
Founded
2007
Specialties
imaging clinical trials , clinical trial services, radiology expertise, project management imaging, central image review, oncology clinical trials, immunology, neuroscience, rare diseases, pain trials, imaging endpoints, exploratory imaging endpoints, drug safety , drug efficacy, rheumatology, neuro-oncology, and neurodegenerative diseases

Locations

Employees at IMAGE ANALYSIS GROUP

Updates

Similar pages

Browse jobs

Funding

IMAGE ANALYSIS GROUP 1 total round

Last Round

Series unknown

US$ 5.2M

Investors

RBV Capital
See more info on crunchbase